What Nurse Navigators Need for Better Lung Nodule Follow-Up

What Nurse Navigators Wish Health Systems Understood About Lung Nodule Follow Ups

Lung cancer remains the deadliest cancer in the United States. In 2022, 218,893 new lung cancers were reported and 131,584 people died from lung cancer in the U.S. Fewer than 1 in 3 cases is detected at an early, localized stage. Most lung cancers are found only after they have spread, when 5-year survival is about 9%. Nurse navigators know that catching cancer early, often through lung nodule follow up, is vital to turning the tide. Each pulmonary nodule flagged on an X-ray or CT scan represents a critical moment: the chance to diagnose lung cancer when cure is still possible. But in practice, many nodules fall through the cracks. As one review found, almost 50% of patients with incidental lung nodules never had follow-up scheduled. To improve lung cancer early diagnosis, health systems must address the real-world challenges of nodule tracking.

Challenges Facing Lung Nodule Follow-Up

Nurse navigators shoulder a heavy burden in lung nodule management. They coordinate care for patients who often have multiple tests and specialists, and they must ensure that every suspicious finding leads to the right next step. Key pain points include:

Volume and complexity of nodules. In the U.S. there are about 93 million chest CT scans each year, yielding well over 1.6 million lung nodules annually. The majority are found incidentally (on scans done for other reasons) and must be sorted by risk. Each nodule must be evaluated against guidelines (e.g. Fleischner Society) to decide on follow-up imaging or referral. Navigators report that managing this sheer number of nodules is overwhelming without help.
Manual tracking and administrative load. Traditionally, follow-up has required extensive paperwork and outreach: writing letters to patients and providers, scheduling appointments or scans, and tracking results. One hospital system found that relying on nurses to manually review reports and arrange follow-up created a backlog of 6–9 months. Manual processes strain staff capacity and delay action.
Incomplete information in reports. Radiology reports often lack clear follow-up instructions. In one study, only 48% of radiology reports contained an explicit recommendation for nodule follow-up. Without a clear note, nurses and providers may miss the need for repeat imaging.
Poor communication between providers. Lung nodules often involve multiple clinicians (emergency, hospitalists, pulmonologists, primary care). Busy primary care providers may not see or act on incidental findings. In fact, a systematic review found that physicians failed to follow up on 36% of abnormal radiology results. Nurse navigators lament that PCPs “can’t do it alone”, yet no automated system exists to guarantee that an incidental nodule gets a second look.
Patient factors and anxiety. Patients often do not understand the significance of an indeterminate nodule. Those who must wait weeks or months for a follow-up scan can become anxious. Navigators spend time reassuring patients and emphasizing that many nodules are benign, yet emphasizing the importance of follow-up imaging.
Resource and system constraints. Many health systems lack dedicated staff or technology for lung nodule tracking. Nurse navigators often have to cobble together spreadsheets and reminder systems. They report being stretched thin between screening programs, active cancer cases, and incidental nodules. Without a formal IPN program (Incidental Pulmonary Nodule program), nodule management is ad hoc and prone to gaps.

These challenges leave navigators frustrated.

System-Level Gaps in Nodule Management

Beyond individual workloads, systemic issues contribute to missed follow-ups. Health systems often lack an integrated lung nodule tracking software or workflow that closes the loop. Key gaps include:

Lack of standardized tracking. Many organizations have no unified database or registry for nodules. Radiology findings might sit in fragmented IT systems, EHRs, or even paper reports. Nurse navigators say they need “one universal platform” to manage all lung nodules (screening and incidental) as a cohort.

Inconsistent guideline adherence. Although most radiologists know the Fleischner Society guidelines, consistent application is poor. One study found that 78% of radiologists were aware of guidelines but only 59% of practices used them reliably. When follow-up plans are not made according to guidelines, patient care suffers. In some cases, no recommendation was given at all.

Poor communication pathways. An identified nodule may not reach the right person. A radiologist’s note might go only to the ordering physician or be buried in text. Nurse navigators must chase down results and clarify plans. The “Swiss cheese” effect is often cited: a nodule may be spotted on a scan (hole in one slice of cheese), a follow-up plan might be written (next slice), but during transitions (hospital discharge, clinic visit), the warning can align with another hole and disappear. The result is that patients “are lost to follow-up in transitions of care”.

Overburdened primary care. Primary care physicians are crucial partners in nodule follow-up, but they are already overbooked. One team noted that PCPs often lack time or resources to chase incidental nodules. Unless there is a clear referral to a lung program or navigator, these patients can slip through the net.

Data overload. With rising imaging, each radiologist or clinician sees dozens of scans daily. Even if one-third of CTs show incidental findings, busy providers simply cannot act on all of them without decision support. Nurse navigators need tools that automatically sift through reports to flag true nodules.

These system gaps mean that the burden of follow-up often falls unfairly on navigators and patients. Navigators frequently wish for a formal incidental pulmonary nodule (IPN) program - a coordinated process (often with software support) to capture every newly reported nodule and manage its course systematically.

Follow-Up Is Where the Risk Lives

Nurse navigators emphasize that follow-up is a high-stakes juncture. This is the point where potential cancers are caught – or lost. Key reasons why missed follow-up is so dangerous:

Tumor growth and progression. A missed follow-up can allow a nodule to grow unchecked. In one study, of patients who did not receive the recommended follow-up, 40% of nodules had increased in size over time. Nodules that grow are at higher risk of malignancy, meaning that a curable cancer might progress to an incurable stage. Early diagnosis offers the chance of curative therapy (surgery, localized radiation).
High non-adherence rates. Follow-up adherence is disturbingly low. Depending on the setting, only about half of patients complete guideline-recommended imaging. Each patient lost means another potential delay in diagnosis. In those lost-to-follow-up groups, the consequences were real: delayed diagnoses and progressed disease.
Delayed treatment and worse outcomes. When follow-up is delayed, even identifiable cancers get treated later. Lung cancer is unforgiving: a tumor confined to the lung has a very different prognosis than one that has spread. Study data make this clear.
Lost opportunities. Every missed follow-up is a lost opportunity for early intervention. One review noted that without follow-up, patients experienced “stage progression and decreased treatment survival”. Nurse navigators see this every day: a nodule that could have been surveilled turns out to be advanced cancer months later.

In short, the follow-up phase is a critical safeguard. When it fails, the system fails the patient. Nurse navigators know this well and point out that robust follow-up is central to the whole goal of lung cancer early diagnosis.

What Nurse Navigators Need from Health Systems

Given these realities, nurse navigators have clear needs for their health systems:

Integrated tracking system. Navigators want an automated way to capture every new nodule. This might be software that flags reported nodules in radiology information systems or an IPN program that uses AI/NLP to comb all imaging reports. Crucially, such a system should link to the EHR and route cases to the navigation team. One success story notes that having “one universal platform to manage both incidental lung nodule patients and lung cancer screening patients” greatly improved efficiency.
Automation of routine tasks. Nurses spend hours on letters and reminders. They need tools to generate these automatically. For example, some programs used a platform that created letters and reminders, letting nurses devote time to complex cases. Mail-merge letters and smart scheduling can save dozens of hours per week.
Adequate staffing and defined roles. A formal lung nodule program should have dedicated coordinators, pulmonary specialists, and clear referral pathways. Navigators often recommend establishing a lung nodule clinic or workflow where any flagged nodule is automatically referred to a specialist or navigator. This avoids the uncertainty of waiting for a PCP to notice.
Clear workflows and protocols. Every team member should know the protocol: which nodules require which follow-up interval, and who is responsible for ordering it. Checklists or “nodule trackers” help ensure nothing is missed. Multidisciplinary reviews can be useful for tricky cases.
Education and communication. Radiologists, PCPs, and patients all benefit from education. Radiology teams need to be vigilant about reporting actionable follow-up. Primary care needs to understand the program, so they cooperate. At some health systems, internal training and documentation helped doctors learn how to use the tracking tools and counsel patients. Navigators often provide printed materials to patients explaining what a nodule is and why follow-up matters.
Leadership support and data. Nurse navigators need system leaders to back these efforts. This can mean investing in software and personnel. Providing navigators with data (number of nodules tracked, follow-up rates, cancers found) helps justify resources.
Leveraging technology. Finally, navigators recognize that technology can help. Patient tracking software, shared EHR inboxes, and even mobile apps can streamline follow-up. A critical enabler is a shared EHR: where it is found that when “everyone working in the same instance, with a single medical record,” it allowed “seamless handoffs” between radiology, navigation, and clinics.

In summary, nurse navigators call for a close-loop program – often called an IPN (incidental pulmonary nodule) program – that ensures every lung nodule is identified, tracked, and resolved. They advocate for tools that reduce manual burden and keep patients from slipping through cracks. As one navigation report concluded, “the nurse navigators noted improved efficiency and reporting” once such systems were in place.

How Qure.ai Helps Close the Gaps

Artificial intelligence can play a key role in supporting navigators’ work. For example, Qure.ai’s Lung Cancer Suite is an FDA-cleared software suite designed to catch nodules early and track them over time. It includes two main tools:

qXR-LN (Chest X-Ray CADe). This is an AI “second reader” for routine chest X-rays. It automatically analyzes adult chest X-rays and highlights any suspected nodules in the 6–30 mm range. In practice, qXR-LN identifies subtle nodules that might be overlooked, helping radiologists prioritize them even in busy settings. A radiologist can then ensure follow-up imaging is ordered.
qCT LN Quant (CT Nodule Tracking). This deep-learning tool works on CT scans. It conducts quantitative measurement and volumetry of user identified nodules. Crucially, it can track the same nodule across multiple timepoints, calculating precise size and volume changes. Navigators and clinicians get objective data on how each nodule grows (or stays stable).

Both tools are FDA-cleared and built for real-world workflows. They integrate into the PACS/RIS so that AI overlay and measurements appear in the routine reading workflow. This preserves physician control while enhancing detection. In effect, Qure.ai provides lung nodule tracking software capabilities: it automates the spotting and measuring of nodules, making sure nothing is missed. The suite is specifically designed to support evidence-based follow-up – for instance, by providing exact growth rates and alerts – which aligns with navigators’ goal of reliable, standardized tracking.

Importantly, these AI tools address specific navigator needs. By ensuring that virtually all nodules are identified (on X-ray or CT), Qure.ai helps make an IPN program feasible. Having a nodule’s history and growth quantified also empowers the care team to apply guidelines confidently. While nurse navigators focus on patient communication and scheduling, AI aids the radiology side to deliver clean data. Together, this allows more efficient management: navigators only spend time on nodules that truly need intervention.

For health systems seeking to improve lung nodule follow-up, these tools are no magic bullet - they still require a coordinated program. But they are cleared and proven components that strengthen the workflow.

Learn more about Qure.ai’s lung cancer AI solutions by downloading the product brochure. The brochure describes the FDA-cleared qXR-LN and qCT LN Quant tools, along with qTrack, which together form a comprehensive lung nodule detection and tracking suite. These technologies are explicitly designed to fit into radiology workflows and augment clinicians, helping ensure that no nodule, and no patient is left behind.